123 results
8-K
EX-99.1
MRNA
Moderna Inc
2 May 24
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
6:31am
as a percentage of net product sales in 2024 was driven by the lower sales level compared to the prior year.
Research and Development Expenses: Research … in the Company’s cash position during the first quarter of 2024 was largely attributable to research and development expenses and operating activities.
2024
PRE 14A
MRNA
Moderna Inc
11 Mar 24
Preliminary proxy
4:08pm
The Board continued to oversee significant capital allocation decisions in 2023. This included investments in research & development to advance our … multiple therapeutic areas. Dr. Horning provides valuable insight to our research and development teams as they develop products across our portfolio
8-K
EX-99.1
pibc jk2wl9uvz
22 Feb 24
Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates
6:32am
8-K
EX-99.1
b0a26d18jjd1m2
2 Nov 23
Moderna Reports Third Quarter 2023 Financial Results and Provides Business Updates
6:33am
8-K
bxwgvbetiyhpon8
11 Sep 23
Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
8:08am
8-K
EX-99.1
4j90fitq7ohj0gm36s9g
11 Sep 23
Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
8:08am
8-K
EX-99.1
tir5xx8v 96sf
3 Aug 23
Moderna Reports Second Quarter 2023 Financial Results and Provides Business Updates
6:33am
S-3ASR
ufttmeo xm
5 May 23
Automatic shelf registration
7:31am
8-K
EX-99.1
3e5ux58 nreg5px
4 May 23
Moderna Reports First Quarter 2023 Financial Results and Provides Business Updates
6:33am
8-K
EX-99.1
en92y2a1 j36wx
3 Nov 22
Moderna Reports Third Quarter 2022 Financial Results and Provides Business Updates
7:04am
8-K
EX-99.1
fls67xc c8nzi8fqzd
3 Aug 22
Moderna Reports Second Quarter 2022 Financial Results and Provides Business Updates
7:04am